Recent data which were obtained in an Italian cohort of adult and pediatric UC and CD patients demonstrated that specific IL-33 and ST2 gene polymorphisms confer an increased risk of developing IBD (both UC and CD), suggesting the involvement of the IL-33/ST2 axis in the onset of chronic intestinal inflammation [100]. This evidence concerns the gene IL1RL1 and inflammatory bowel disease.